Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Erythrocyte concentrates]

F Schooneman1

  • 1Centre Régional de Transfusion Sanguine et d'Hématologie, Vandoeuvre-les-Nancy.

Cahiers D'Anesthesiologie
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Red blood cell concentrates are the most common blood product for anemia treatment. Selecting the best product requires evaluating patient disease risks and transfusion side effects for optimal safety.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HTLV-I infection in the South West Indian Ocean islands, particularly in La Réunion and the Seychelles.

Bulletin de la Societe de pathologie exotique (1990)·2013
Same author

Pathogen inactivation of platelet concentrates.

Vox sanguinis·2010
Same author

[Novel criteria for assessing red blood cell viability in blood banks].

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2007
Same author

Two red blood cell units collected in SAG-M additive solution with the ALYX component collection system.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2005
Same author

[Apheresis donation. Current views and perspectives].

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2005
Same author

Extracorporeal photopheresis technical aspects.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2003
Same journal

[The Ombredanne equipment].

Cahiers d'anesthesiologie·1996
Same journal

[Comparison of the efficacy of 2 antiseptic solutions in the prevention of infection from peridural catheters].

Cahiers d'anesthesiologie·1996
Same journal

[Caudal and spinal anesthesia in sub-umbilical surgery in children. Apropos of 1875 cases].

Cahiers d'anesthesiologie·1996
Same journal

[Evaluation of the cost of autologous erythrocyte concentrates in a hospital].

Cahiers d'anesthesiologie·1996
Same journal

[Combination of propofol-ketamine-vecuronium for total intravenous anesthesia under hazardous conditions].

Cahiers d'anesthesiologie·1996
Same journal

[Venous surgery of the lower limb: value of nerve blocks].

Cahiers d'anesthesiologie·1996
See all related articles

Area of Science:

  • Hematology
  • Transfusion Medicine
  • Clinical Pathology

Context:

  • Blood banks distribute various blood products, with red cell concentrates being the most frequently prescribed.
  • Anemia is a primary indication for red blood cell transfusions.
  • Advancements in preparation allow for tailored red cell concentrates to meet individual patient needs.

Purpose:

  • To highlight the importance of selecting appropriate red cell concentrates for patients.
  • To emphasize the need for a comprehensive risk-benefit assessment in red blood cell transfusion decisions.

Summary:

  • Red cell concentrates are the predominant blood product used for anemia management.
  • A wide array of specialized red cell concentrates are available, facilitating personalized patient care.

Related Experiment Videos

  • Optimal selection involves assessing patient-specific disease risks alongside potential transfusion-related side effects.

    • Impact:

    • Informed selection of red cell concentrates can enhance transfusion efficacy.
    • Evaluating risks and side effects contributes to safer transfusion practices.
    • Personalized transfusion strategies improve patient outcomes in anemia treatment.